Skip to main content
. 2021 Apr;21(2):246–251. doi: 10.17305/bjbms.2020.5106

FIGURE 4.

FIGURE 4

The treatment process of the patient. *D3 used half the drug dose. Aberration: ATO, arsenic trioxide; ATRA, all-trans retinoic acid; DNR, daunorubicin; PLD: pegylated liposomal doxorubicin; Ara-C: Cytarabine; FCM: Flow cytometer; qPCR: Quantitative polymerase chain reaction; FISH: Fluorescence in situ hybridization.